Clinitech Laboratory Ltd

Clinitech Lab Summary Chart Analysis Peers Quarters Profit & Loss Balance Sheet Cash Flow Ratios Investors Documents

Clinitech Laboratory Ltd

₹ 38.0 0.53%
10 Jun 4:01 p.m.
ctllab.in BSE - SME: 544220
About

Incorporated in 1990, Clinitech Laboratory Ltd is in the business of providing pathology and related healthcare services.[1]

Key Points

Business Overview:[1]
CTLL in the business of providing NABL
accredited healthcare services such as:
a) Pathology testing labs
b) Diagnostic centres
c) Scan centres
d) X-ray centres
e) ECG clinics

Website BSE
  • Market Cap ₹ 8.68 Cr.
  • Current Price ₹ 38.0
  • High / Low ₹ 57.0 / 28.6
  • Stock P/E 20.7
  • Book Value ₹ 40.5
  • Dividend Yield 0.00 %
  • ROCE 7.27 %
  • ROE 4.65 %
  • Face Value ₹ 10.0
Edit ratios

Pros

  • Company is almost debt free.
  • Stock is trading at 0.94 times its book value
  • Promoter holding has increased by 1.78% over last quarter.

Cons

  • Though the company is reporting repeated profits, it is not paying out dividend
  • Company has a low return on equity of 6.16% over last 3 years.
  • Debtor days have increased from 57.9 to 71.2 days.
  • Working capital days have increased from 100 days to 164 days

* The pros and cons are machine generated. Pros / cons are based on a checklist to highlight important points. Please exercise caution and do your own analysis.

Peer comparison

Healthcare Healthcare Healthcare Services Healthcare Service Provider

Edit Columns
Loading peers table ...

Half Yearly Results

Standalone Figures in Rs. Crores / View Consolidated

Sep 2023 Mar 2024 Sep 2024 Mar 2025 Sep 2025 Mar 2026
3.06 3.34 4.08 4.16 5.08 4.39
2.78 2.61 3.52 3.88 4.54 3.94
Operating Profit 0.28 0.73 0.56 0.28 0.54 0.45
OPM % 9.15% 21.86% 13.73% 6.73% 10.63% 10.25%
0.02 0.01 0.05 0.17 0.11 0.08
Interest 0.04 0.06 0.04 0.02 0.05 0.02
Depreciation 0.19 0.25 0.31 0.14 0.25 0.26
Profit before tax 0.07 0.43 0.26 0.29 0.35 0.25
Tax % 14.29% 30.23% 15.38% 41.38% 14.29% 52.00%
0.07 0.30 0.22 0.17 0.30 0.12
EPS in Rs 0.47 1.79 0.96 0.74 1.31 0.53
Raw PDF

Profit & Loss

Standalone Figures in Rs. Crores / View Consolidated

Mar 2021 Mar 2022 Mar 2023 Mar 2024 Mar 2025 Mar 2026
4.55 6.38 6.35 6.40 8.23 9.48
3.72 5.31 4.99 5.41 7.40 8.49
Operating Profit 0.83 1.07 1.36 0.99 0.83 0.99
OPM % 18.24% 16.77% 21.42% 15.47% 10.09% 10.44%
0.04 0.07 0.02 0.04 0.23 0.19
Interest 0.08 0.06 0.07 0.09 0.06 0.07
Depreciation 0.25 0.38 0.45 0.44 0.45 0.51
Profit before tax 0.54 0.70 0.86 0.50 0.55 0.60
Tax % 25.93% 27.14% 29.07% 26.00% 29.09% 30.00%
0.40 0.51 0.61 0.37 0.39 0.42
EPS in Rs 6.00 3.40 4.07 2.20 1.71 1.84
Dividend Payout % 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Compounded Sales Growth
10 Years: %
5 Years: 16%
3 Years: 14%
TTM: 15%
Compounded Profit Growth
10 Years: %
5 Years: 3%
3 Years: -12%
TTM: 24%
Stock Price CAGR
10 Years: %
5 Years: %
3 Years: %
1 Year: 5%
Return on Equity
10 Years: %
5 Years: 10%
3 Years: 6%
Last Year: 5%

Balance Sheet

Standalone Figures in Rs. Crores / View Consolidated

Mar 2021 Mar 2022 Mar 2023 Mar 2024 Mar 2025 Mar 2026
Equity Capital 0.67 1.50 1.50 1.68 2.28 2.28
Reserves 0.72 0.35 0.88 1.87 6.55 6.97
0.54 0.89 1.03 0.87 0.00 0.36
0.80 0.94 2.62 1.19 1.88 1.30
Total Liabilities 2.73 3.68 6.03 5.61 10.71 10.91
0.84 1.65 1.33 1.71 2.12 3.17
CWIP 0.08 0.41 0.56 0.94 1.01 0.00
Investments 0.09 0.14 2.02 0.07 0.07 0.08
1.72 1.48 2.12 2.89 7.51 7.66
Total Assets 2.73 3.68 6.03 5.61 10.71 10.91

Cash Flows

Standalone Figures in Rs. Crores / View Consolidated

Mar 2021 Mar 2022 Mar 2023 Mar 2024 Mar 2025 Mar 2026
0.38 0.96 1.25 -1.28 -0.88 -0.90
0.54 -1.47 -0.65 0.75 -0.73 -0.44
-0.88 0.29 0.09 0.45 3.98 0.33
Net Cash Flow 0.04 -0.22 0.68 -0.08 2.37 -1.01
Free Cash Flow 0.19 -0.55 0.97 -2.49 -1.73 -1.45
CFO/OP 64% 109% 114% -115% -87% -70%

Ratios

Standalone Figures in Rs. Crores / View Consolidated

Mar 2021 Mar 2022 Mar 2023 Mar 2024 Mar 2025 Mar 2026
Debtor Days 44.92 20.60 28.17 34.22 68.30 71.23
Inventory Days 32.21 40.28 43.68 92.91 124.01 118.42
Days Payable 164.61 130.90 124.79 116.14 147.40 64.89
Cash Conversion Cycle -87.48 -70.03 -52.95 10.99 44.90 124.76
Working Capital Days 43.32 -4.58 -33.34 21.67 114.87 163.63
ROCE % 32.55% 30.24% 14.81% 8.15% 7.27%

Insights

In beta
Mar 2024 Mar 2025
Clinical Test Receipts Revenue (Proxy for Volume)
INR Lakhs

Log in to view insights

Please log in to see hidden values.

Login
Debtors Turnover Ratio
Times
Number of Permanent Employees
Count

Extracted by Screener AI

Shareholding Pattern

Numbers in percentages

18 Recently
Sep 2024Mar 2025Sep 2025Mar 2026
61.58% 61.58% 62.42% 64.21%
0.32% 0.32% 0.32% 0.32%
38.11% 38.11% 37.27% 35.49%
No. of Shareholders 346303303297

* The classifications might have changed from Sep'2022 onwards. The new XBRL format added more details from Sep'22 onwards.

Classifications such as banks and foreign portfolio investors were not available earlier. The sudden changes in FII or DII can be because of these changes.

Click on the line-items to see the names of individual entities.

Documents

Announcements

Annual reports